[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-331697-105":59,"doc-detail-331697-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","histopathological-spectrum-of-ovarian-tumors-in-jharkhand-india-a-retrospective-study","Histopathological spectrum of ovarian tumors in Jharkhand, India - A retrospective study","","Ovarian tumors represent the most prevalent neoplasms worldwide, with projected increases in ovarian cancer incidence and mortality by 2050. This retrospective study analyzed 190 histopathologically confirmed ovarian tumor cases from March 2020 to March 2024 at a tertiary care center in Jharkhand, classifying tumors using the 2020 WHO scheme and evaluating age distribution, incidence frequency, and laterality. Results showed 81.1% benign, 4.2% borderline, and 14.7% malignant tumors, with surface epithelial tumors predominating.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/histopathological-spectrum-of-ovarian-tumors-in-jharkhand-india-a-retrospective-study/331697/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/histopathological-spectrum-of-ovarian-tumors-in-jharkhand-india-a-retrospective-study/331697.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the retrospective study?","Question",{"text":112,"@type":113},"To analyze the histopathological spectra of ovarian tumors in line with the 2020 WHO classification and assess age distribution, incidence frequency, and laterality of different subtypes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many ovarian tumor cases were included, and what time period did they cover?",{"text":117,"@type":113},"The study included 190 histopathologically proven cases reported from March 2020 to March 2024.",{"name":119,"@type":110,"acceptedAnswer":120},"What proportions of tumors were benign, borderline, and malignant?",{"text":121,"@type":113},"Among 190 cases, 81.1% were benign, 4.2% were borderline, and 14.7% were malignant.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},331697,1790197177,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","| \u003Cbr>Original Article\u003Cbr>|\n| --- |\n|  |\n| Histopathological spectrum of ovarian tumors in Jharkhand, India: A retrospective study\u003Cbr>Manoj K . Paswan, Helen M . M . Tudu, Smita Kumari Gupta, Saurav Banerjee,\u003Cbr>Deepali Tirkey\u003Cbr>Histopathology, Department of Pathology, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India |\n| AbstrAct\u003Cbr>Background: Ovarian tumors are the most prevalent neoplasms worldwide, affecting women of all ages. According to Globocan’s 2022 projections, by 2050, the number of women diagnosed with ovarian cancer worldwide will increase by over 55% to 503,448 . The number of women dying from ovarian cancer is projected to increase to 350,956 each year, an increase of almost 70% from 2022. Aims and Objectives: The aim of this study was to analyze the various histopathological spectra of ovarian tumors according to the latest 2020 WHO classification and to assess the age distribution, frequency of incidence, and laterality of different subtypes of ovarian tumors. Materials and Methods: This retrospective study included 190 cases of histopathologically proven ovarian tumors reported by the pathology department from March 2020 to March 2024 at the Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India. Results: A total of 190 cases were studied, 154 (81 . 1%) were benign, 8 (4 . 2%) were borderline, and 28 (14 . 7%) cases were malignant. Surface epithelial tumors (SETs) were the most common (n = 139, 73. 2%), followed by germ cell tumors (GCTs) (n = 38, 20%) . Serous cystadenomas (n = 63, 33%) were the most common benign tumors, whereas the most common malignant tumors were serous carcinomas ( n=11, 5. 7% ) . Most ovarian tumors (n = 45, 23.68%) occurred in the 31–40‑year‑old age group. Conclusion: The present study showed various histopathological patterns of ovarian tumors. This study indicated a slight increase in the prevalence of malignant ovarian tumors in the middle‑aged group and and a relative increase in the percentage of SETs over GCTs in recent years in our tertiary care center in Jharkhand, India. With limited resources in our institute, histopathological examination remains the mainstay for the early diagnosis of these tumors and their timlely and appropriate management.\u003Cbr>Categories: Pathology.\u003Cbr>Keywords: Germ cell tumors, histopathological spectrum, ovarian tumors, surface epithelial tumors, WHO |\n\nIntroduction  \nGlobally, ovarian cancer is the significant cause of higher morbidity and mortality rates among women. It is the eighth most common cancer among women worldwide and the eighth most common cause of cancer‑related death in women. [1]  \nAddress for correspondence: Dr. Smita Kumari Gupta, Department of Pathology, Rajendra Institute of Medical Sciences, Ranchi ‑ 834 009, Jharkhand, India.  \nE‑mail: [smitagupta. 67@gmail.com](smitagupta. 67@gmail.com)  \nReceived: 21‑06‑2024  \nAccepted: 21‑08‑2024  \nRevised: 09‑08‑2024  \nPublished: 09‑12‑2024  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code:\u003Cbr>| Website:\u003Cbr>[http://journals.lww.com/JFMPC](http://journals.lww.com/JFMPC) |\n|  | DOI:\u003Cbr>10.4103/jfmpc.jfmpc_1086_24 |\n\nOvarian cancer is a global concern, and according to the Global Cancer Observatory (GLOBOCON) 2022, 324,603 women have been reported to have ovarian cancer worldwide. By 2050, the number of women diagnosed with ovarian cancer worldwide will increase from 55% to 503448 anually.[2]  \nThe Indian Cancer Registry data project states that the ovary is one of the most important locations for carcinoma, and approximately 8.7% of the cancers in India are due to ovarian causes. [3] Ovarian cancer ranks as the third most common gynecological cancer, followed by cervical and uterine cancers, and has the worst prognosis. [1,4] Ovarian cancer’s highest death rate is due to a lack of specific signs, symptoms, and effective  \nThis is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution‑NonCommerci","cbCaiaVEYGdTmaNc","https://ap.wps.com/l/cbCaiaVEYGdTmaNc","pdf",3762033,"English","# Abstract\n# Introduction\n## Epidemiology and risk factors\n# Materials and Methods\n# Results\n# Conclusion","[{\"question\":\"What was the main objective of the retrospective study?\",\"answer\":\"To analyze the histopathological spectra of ovarian tumors in line with the 2020 WHO classification and assess age distribution, incidence frequency, and laterality of different subtypes.\"},{\"question\":\"How many ovarian tumor cases were included, and what time period did they cover?\",\"answer\":\"The study included 190 histopathologically proven cases reported from March 2020 to March 2024.\"},{\"question\":\"What proportions of tumors were benign, borderline, and malignant?\",\"answer\":\"Among 190 cases, 81.1% were benign, 4.2% were borderline, and 14.7% were malignant.\"}]","Histopathological spectrum of ovarian tumors in Jharkhand, India - A retrospective study | PDF",1789994736,18]